Imaging epileptogenic tubers in children with tuberous sclerosis complex using α-[11C]methyl-L-tryptophan positron emission tomography

Annals of Neurology

Volumn 44, Issue 6, 1998, Pages 858-866

  Chugani, Diane C ^a,b   Chugani, Harry T ^a   Muzik, Otto ^a   Shah, Jagdish R ^a   Shah, Aashit K ^a   Canady, Alexa ^a   Mangner, Thomas J ^a   Chakraborty, Pulak K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBON 11; CLONAZEPAM; FLUORODEOXYGLUCOSE F 18; LAMOTRIGINE; N METHYLTRYPTOPHAN; NITRAZEPAM; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN METABOLISM; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTOGENESIS; FEMALE; GLUCOSE METABOLISM; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEIZURE; TUBEROUS SCLEROSIS;

EID: 0031736092     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440603     Document Type: Article

References (56)

1. Fryer AE, Chalmers A, Conner JM, et al. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1987; 1:659-661
2. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805-808
3. Kandt RS, Haines JL, Smith M, et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 1992;2:37-41
4. Gomez MR. Neurologic and psychiatric features. In: Gomez MR, ed. Tuberous sclerosis. New York: Raven Press, 1988: 21-36
5. Roach ES, Smith M, Huttenlocher P, et al. Report of the diagnostic criteria committee of the National Tuberous Sclerosis Association. J Child Neurol 1992;7:221-224
6. Gomez M. Tuberous sclerosis. In: Gomez MR, ed. Neurocutaneous diseases. Boston: Butterworths, 1987:30-52
7. Bye AM, Matheson JM, Tobias VH, Mackensie RA. Selective epilepsy surgery in tuberous sclerosis. Aust Paediatr J 1989;25: 243-245
8. Andermann F, Palmini AL. Neuronal migration disorders, tuberous sclerosis, and Sturge-Weber syndrome. In: Epilepsy surgery. New York: Raven Press, 1992:203-211
9. Duchowny M, Levin B, Jayakar P, et al. Temporal lobectomy in early childhood. Epilepsia 1992;33:298-303
10. Bebin EM, Kelly PJ, Gomez MR. Surgical treatment for epilepsy in cerebral tuberous sclerosis. Epilepsia 1993;34:651-657
11. Rintahaka PJ, Chugani HT. Clinical role of positron emission tomography in children with tuberous sclerosis complex. J Child Neurol 1997;12:42-52
12. Louw D, Sutherland GB, Glavin GB, Girvin J. A study of monoamine metabolism in human epilepsy. Can J Neurol Sci 1989;16:394-397
13. Pintor M, Mefford IN, Hutter I, et al. The levels of biogenic amines, their metabolites and tyrosine hydroxylase in the human epileptic temporal cortex. Synapse 1990;5:152-156
14. Trottier S, Evrard B, Vignal JP, et al. The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia. Epilepsy Res 1996;25:79-106
15. Diksic M, Nagahiro S, Sourkes TL, Yamamoto YL. A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model. J Cereb Blood Flow Metab 1990;9:1-12
16. Nishizawa S, Benkelfat C, Young SN, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 1997;94:5308-5313
17. Muzik O, Chugani DC, Chakraborty PK, et al. Analysis of (C-11]alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo. J Cereb Blood Flow Metab 1997;17:659-669
18. Chugani DC, Muzik O, Chakraborty PK, et al. Human brain serotonin synthesis capacity measured in vivo with α[C-11]-methyl-L-tryptophan. Synapse 1998;28:33-43
19. Missala K, Sourkes TL. Functional cerebral activity of an analogue of serotonin formed in situ. Neurochem Int 1988;12: 209-214
20. Chakraborty PK, Mangner TJ, Chugani DC, et al. A high yield and simplified procedure for the synthesis of α[C-11]methyl-L-tryptophan. J Label Comp Radiopharmacol 1995;37:619-621
21. Chakraborty PK, Mangner TJ, Chugani DC, et al. A high yield and simplified procedure for the synthesis of α[C-11]methyl-L-tryptophan. Nucl Med Biol 1996;23:1005-1008
22. Muzik O, Chugani DC, Shen C, da Silva E. Non-invasive Imaging of serotonin synthesis rate using PET and [C-11]alpha-methyl-tryptophan. In: Carson RE, Daube-Witherspoon ME, Hercovitch P, eds. Quantitative functional brain imaging with positron emission tomography. New York: Academic Press, 1997:201-206
23. Chugani HT, Phelps ME, Mazziotta JC. Positron emission tomography study of human brain functional development. Ann Neurol 1987;22:487-497
24. Kuhn DM, Lovenberg W. Assays of serotonin, related metabolites and tryptophan hydroxylase. In: Parvez H, Parvez S, Nagatsu I, Natasu T, eds. Methods in biogenic amine research. Amsterdam: Elsevier, 1983;515-548
25. Wolf WA, Kuhn DM. The uptake and release of tryptophan and serotonin: an HPLC method to study the flux of endogenous 5-hydroxyindoles through synaptosomes. J Neurochem 1986;46:61-67
26. Brooks RA, Di Chiro G, Zukerberg BW, et al. Test-retest studies of cerebral glucose metabolism using fluorine-18 deoxyglucose: validation of method. J Nucl Med 1987;28: 53-59
27. Kenney JM, Marinelli LD, Woodard HQ. Tracer studies with radioactive phosphorus in malignant neoplastic disease. Radiology 1941;37:683-690
28. Woodard HQ, Gigler RE, Freed B, Russ G. Expression of tissue isotope distribution. J Nucl Med 1975;16:958-959
29. Pietrzyk U, Herholz K, Heiss WD. Three-dimensional alignment of functional and morphological tomograms. J Comput Assist Tomogr 1990;14:51-59
30. Pietrzyk U, Herholz K, Fink G, et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med 1994;35: 2011-2018
31. Foley J, van Dam A, Feiner S, Hughes J. Computer graphics: principles and practice. Menlo Park, CA: Addison-Wesley, 1990:702
32. Lorenson C, Kline D. "Marching cubes": a high resolution 3D-surface construction algorithm. Comput Graphics 1987;21: 163-169
33. Szelies B, Herholz K, Heiss WD, et al. Hypometabolic cortical lesions in tuberous sclerosis with epilepsy: demonstration by positron emission tomography. J Comput Assist Tomogr 1983; 7:946-953
34. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-647
35. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184:441-444
36. Vanier M, Tsuiki K, Grdisa M, et al. Determination of the lumped constant for the α-methyltryptophan method of estimating the rate of serotonin synthesis. J Neurochem 1995;64: 624-635
37. Shoaf SE, Schmall B. Pharmacokinetics of α-methyl-L-tryptophan in rhesus monkeys and calculation of the lumped constant for estimating the rate of serotonin synthesis. J Pharmacol Exp Ther 1996;277:219-224
38. Chugani DC, Muzik O, Rothermel R, et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997;42:666-669
39. Ferrer I, Fabregues I, Coll J, et al. Tuberous sclerosis: a Golgi study of cortical tuber. Clin Neuropathol 1984;3:47-51
40. Huttenlocher PR, Heydemann PT. Fine structure of cortical tubers in tuberous sclerosis: a Golgi study. Ann Neurol 1984; 16:595-602
41. Machado-Salas JP. Abnormal dendritic patterns and aberrant spine development of Bourneville's disease - a Golgi survey. Clin Neuropathol 1984;3:52-58
42. Kingsley DPE, Kendal BE, Fritz CT. Tuberous sclerosis: a clinico-radiological evaluation of 110 cases with reference of atypical presentation. Neuroradiology 1986;28:38-46
43. Boesel CP, Paulson GW, Kosnik EJ, Earle KM. Brain hamartomas and tumors associated with tuberous sclerosis. Neurosurgery 1979;4:410-417
44. Shepherd CW, Houser OW, Gomez MR. MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. Am J Neuroradiol 1995;16:149-155
45. Curatolo P, Cusmai R, Pruna D. Tuberous sclerosis: diagnostic and prognostic problems. Pediatr Neurosci 1986;12:123-125
46. Roach ES, Williams DP, Laster DW. Magnetic resonance imaging in tuberous sclerosis. Arch Neurol 1987;44:301-304
47. Nixon JR, Houser OW, Gomez MR, Okazaki H. Cerebral tuberous sclerosis: MR imaging. Radiology 1989;170:869-873
48. Cusmai R, Chiron C, Curatolo P, et al. Topographic comparative study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis. Epilepsia 1990; 31:747-755
49. Chugani HT, Rintahaka PJ, Shewmon DA. Ictal patterns of cerebral glucose utilization in children with epilepsy. Epilepsia 1994;35:813-822
50. Dailey JW, Reigel CE, Mishra PK, Jobe PC. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res 1989;3:317-320
51. Statnick MA, Dailey JW, Jobe PC, Browning RA. Abnormalities in brain serotonin concentration, high-affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats. Epilepsia 1996;37:311-321
52. Wenger GR, Stitzel RE, Craig CR. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse. Neuropharmacology 1973;12: 693-703
53. Lazarova M, Bendotti C, Samanin R. Studies on the role of serotonin in different regions of the rat central nervous system on pentylenetetrazol-induced seizures and the effect of di-n-propyl-lacetate. Arch Pharmacol 1983;322:147-152
54. Pallistet PD. Aggravation of epilepsy by reserpine, associated with possible bleeding and clotting disturbances. Rocky Mt Med J 1982;56:45-50
55. Maynert E, Marczynski T, Browning R. The role of neurotransmitters in the epilepsies. Adv Neurol 1975;13:79-147
56. Chugani DC, da Silva EA, Muzik O, et al. Abnormal serotonin synthesis in epileptic foci of children: an in vivo study with alpha[C-11]methyl-tryptophan and positron emission tomography. Twenty-second international epilepsy congress, Dublin, Ireland. Epilepsia 1997;38(Suppl 3):45 (Abstract)